Survival benefit of gastrectomy ± metastasectomy in patients with metastatic gastric cancer receiving chemotherapy

Gastric Cancer

Volumn 14, Issue 2, 2011, Pages 130-138

  Kim, Ki Hwan ^a   Lee, Keun Wook ^a   Baek, Sun Kyung ^a   Chang, Hye Jung ^a   Kim, Yu Jung ^a   Park, Do Joong ^a   Kim, Jee Hyun ^a   Kim, Hyung Ho ^a   Lee, Jong Seok ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

Debulking gastrectomy; Metastasectomy; Metastasis; Stomach cancer

Indexed keywords

FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; OXALIPLATIN; PLATINUM COMPLEX; TAXANE DERIVATIVE;

ADULT; AGED; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; GASTRECTOMY; HOSPITALIZATION; HUMAN; ILEUS; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS RESECTION; OVARY METASTASIS; OVERALL SURVIVAL; PERITONEUM METASTASIS; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; SURGICAL INFECTION; SURVIVAL RATE; SURVIVAL TIME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; GASTRECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 79959378068     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-011-0015-7     Document Type: Article

References (29)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108 15761078 10.3322/canjclin.55.2.74 (Pubitemid 40372904)
2. AI Sarela S Yelluri 2007 Gastric adenocarcinoma with distant metastasis: is gastrectomy necessary? Arch Surg 142 143 149 17309965 10.1001/archsurg.142.2. 143 discussion 149 (Pubitemid 46294133)
3. TJ Miner DP Jaques MS Karpeh MF Brennan 2004 Defining palliative surgery in patients receiving noncurative resections for gastric cancer J Am Coll Surg 198 1013 1021 15194084 10.1016/j.jamcollsurg.2004.02.007 (Pubitemid 38759852)
4. SH Cheon SY Rha HC Jeung CK Im SH Kim HR Kim, et al. 2008 Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases Ann Oncol 19 1146 1153 18304963 10.1093/annonc/mdn026 1:STN:280:DC%2BD1czktlSrtg%3D%3D (Pubitemid 351796341)
5. JH Cheong WJ Hyung J Chen J Kim SH Choi SH Noh 2004 Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer Gynecol Oncol 94 477 482 15297191 10.1016/j.ygyno.2004.05.007 (Pubitemid 39024556)
6. O Glehen V Schreiber E Cotte AC Sayag-Beaujard D Osinsky G Freyer, et al. 2004 Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer Arch Surg 139 20 26 14718269 10.1001/archsurg.139.1.20 1:STN:280:DC%2BD2c%2FitVKqtg%3D%3D (Pubitemid 38049613)
7. JS Gold DP Jaques DJ Bentrem MA Shah LH Tang MF Brennan, et al. 2007 Outcome of patients with known metastatic gastric cancer undergoing resection with therapeutic intent Ann Surg Oncol 14 365 372 17146744 10.1245/s10434-006- 9059-z (Pubitemid 46175277)
8. JJ Hall BW Loggie P Shen S Beamer L Douglas Case R McQuellon, et al. 2004 Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer J Gastrointest Surg 8 454 463 15120371 10.1016/j.gassur.2003.12.014 (Pubitemid 38561210)
9. Y Sakamoto T Sano K Shimada M Esaki M Saka T Fukagawa, et al. 2007 Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer J Surg Oncol 95 534 539 17219383 10.1002/jso.20739 (Pubitemid 47177216)
10. Y Yonemura T Kawamura E Bandou S Takahashi T Sawa N Matsuki 2005 Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion Br J Surg 92 370 375 15739249 10.1002/bjs.4695 1:STN:280:DC%2BD2M7hslyhtQ%3D%3D (Pubitemid 40445602)
11. SZ Lin HF Tong T You YJ Yu WJ Wu C Chen, et al. 2008 Palliative gastrectomy and chemotherapy for stage IV gastric cancer J Cancer Res Clin Oncol 134 187 192 17611776 10.1007/s00432-007-0268-z 1:CAS:528:DC%2BD2sXhsVSls7bL (Pubitemid 350234063)
12. S Lim BE Muhs SG Marcus E Newman RS Berman SP Hiotis 2007 Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups? J Surg Oncol 95 118 122 17262741 10.1002/jso.20328 (Pubitemid 46238979)
13. RF Saidi SG ReMine PS Dudrick NN Hanna 2006 Is there a role for palliative gastrectomy in patients with stage IV gastric cancer? World J Surg 30 21 27 16369718 10.1007/s00268-005-0129-3 (Pubitemid 43081609)
14. JJ Bonenkamp M Sasako J Hermans CJ van de Velde 2001 Tumor load and surgical palliation in gastric cancer Hepatogastroenterology 48 1219 1221 11677934 1:STN:280:DC%2BD3MrntFWqtQ%3D%3D (Pubitemid 33010395)
15. HH Hartgrink H Putter E Klein Kranenbarg JJ Bonenkamp CJ van de Velde 2002 Value of palliative resection in gastric cancer Br J Surg 89 1438 1443 12390389 10.1046/j.1365-2168.2002.02220.x 1:STN:280:DC%2BD38njt1anug%3D%3D
16. S Kikuchi Y Arai M Morise N Kobayashi H Tsukamoto H Shimao, et al. 1998 Gastric cancer with metastases to the distant peritoneum: a 20-year surgical experience Hepatogastroenterology 45 1183 1188 9756030 1:STN:280: DyaK1cvislClsw%3D%3D (Pubitemid 28403315)
17. S Maekawa M Saku Y Maehara N Sadanaga K Ikejiri H Anai, et al. 1996 Surgical treatment for advanced gastric cancer Hepatogastroenterology 43 178 186 8682459 1:STN:280:DyaK283mvVOrsQ%3D%3D (Pubitemid 26083781)
18. K Ouchi T Sugawara H Ono T Fujiya Y Kamiyama Y Kakugawa, et al. 1998 Therapeutic significance of palliative operations for gastric cancer for survival and quality of life J Surg Oncol 69 41 44 9762890 10.1002/(SICI)1096- 9098(199809)69:1<41::AID-JSO8>3.0.CO;2-K 1:STN:280:DyaK1cvjtlymtg%3D%3D (Pubitemid 28452272)
19. Ajani JA, NCCN Panel. National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology: gastric cancer (V.2.2010). in ed; 2010.
20. AD Wagner W Grothe J Haerting G Kleber A Grothey WE Fleig 2006 Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data J Clin Oncol 24 2903 2909 16782930 10.1200/JCO.2005.05. 0245 1:CAS:528:DC%2BD28XntV2gs7s%3D (Pubitemid 46630593)
21. IS Choi DY Oh BS Kim KW Lee JH Kim JS Lee 2007 Oxaliplatin, 5-FU, folinic acid as first-line palliative chemotherapy in elderly patients with metastatic or recurrent gastric cancer Cancer Res Treat 39 99 103 19746224 10.4143/crt.2007.39.3.99
22. KW Lee SM Bang S Kim HJ Lee DY Shin Y Koh, et al. 2010 The incidence, risk factors and prognostic implications of venous thromboembolism in patients with gastric cancer J Thromb Haemost 8 540 547 20040044 10.1111/j.1538-7836. 2009.03731.x 1:STN:280:DC%2BC3c3mslynuw%3D%3D
23. Greene F, Page D, Fleming I, Fritz A, Balch C, Haller D. AJCC cancer staging manual. 6th ed. New York, NY: Springer-Verlag; 2002.
24. Japanese Research Society for Gastric Cancer. Japanese classification of gastric carcinoma. 1st English edition. Tokyo: Kanehara; 1995.
25. An JY, Ha TK, Noh JH, Sohn TS, Kim S. Proposal to subclassify stage IV gastric cancer into IVA, IVB, and IVM. Arch Surg 2009;144:38-45; discussion 45.
26. C Li M Yan J Chen M Xiang ZG Zhu YZ Lin 2009 Prognostic influence of sub-stages according to pTNM categories in patients with stage IV gastric cancer J Surg Oncol 99 324 328 19204941 10.1002/jso.21242
27. Edge SB, Byrd DR, Carducci MA, et al., editors. American Joint Committee on Cancer (AJCC) Cancer Staging Manual. 7th ed. New York: Springer; 2009.
28. J Zacherl M Zacherl C Scheuba R Steininger E Wenzl F Muhlbacher, et al. 2002 Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma J Gastrointest Surg 6 682 689 12399057 10.1016/S1091-255X(01) 00075-0 (Pubitemid 40433486)
29. K Fujitani HK Yang Y Kurokawa DJ Park T Tsujinaka BJ Park, et al. 2008 Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan Clinical Oncology Group Study JCOG 0705 and Korea Gastric Cancer Association Study KGCA01 Jpn J Clin Oncol 38 504 506 18617536 10.1093/jjco/hyn058